- Home
- BR vs A Comparison
BR vs A Comparison
Compare BR & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BR
- A
- Stock Information
- Founded
- BR 1962
- A 1999
- Country
- BR United States
- A United States
- Employees
- BR N/A
- A N/A
- Industry
- BR Business Services
- A Biotechnology: Laboratory Analytical Instruments
- Sector
- BR Consumer Discretionary
- A Industrials
- Exchange
- BR Nasdaq
- A Nasdaq
- Market Cap
- BR 26.6B
- A 29.3B
- IPO Year
- BR 2007
- A 1999
- Fundamental
- Price
- BR $235.85
- A $102.48
- Analyst Decision
- BR Hold
- A Buy
- Analyst Count
- BR 6
- A 13
- Target Price
- BR $241.00
- A $147.33
- AVG Volume (30 Days)
- BR 622.3K
- A 2.7M
- Earning Date
- BR 05-07-2025
- A 05-28-2025
- Dividend Yield
- BR 1.49%
- A 0.97%
- EPS Growth
- BR 11.55
- A 4.31
- EPS
- BR 6.40
- A 4.36
- Revenue
- BR $6,682,900,000.00
- A $6,533,000,000.00
- Revenue This Year
- BR $10.08
- A $5.55
- Revenue Next Year
- BR $5.25
- A $6.07
- P/E Ratio
- BR $36.85
- A $23.51
- Revenue Growth
- BR 5.73
- A N/A
- 52 Week Low
- BR $188.30
- A $96.43
- 52 Week High
- BR $247.01
- A $155.35
- Technical
- Relative Strength Index (RSI)
- BR 52.00
- A 35.47
- Support Level
- BR $232.92
- A $96.43
- Resistance Level
- BR $237.83
- A $106.21
- Average True Range (ATR)
- BR 8.40
- A 5.10
- MACD
- BR 0.46
- A 0.03
- Stochastic Oscillator
- BR 67.82
- A 28.40
About BR Broadridge Financial Solutions Inc.
Broadridge Financial Solutions, which was spun off from Automatic Data Processing in 2007, is a leading provider of investor communication and technology-driven solutions to banks, broker/dealers, traditional and alternative-asset managers, wealth managers, and corporate issuers. Broadridge is composed of two segments: investor communication solutions and global technology and operations.
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.